Showing 71-80 of 94 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20533/Now What?
https://practicaldermatology.com/topics/psoriasis/now-what/20840/A look at what's now, what's next, and how dermatology practice continues to evolve with drugs, technologies, and opportunities.A History of Phlebology: Warts and All, Part 3
https://practicaldermatology.com/topics/practice-management/a-history-of-phlebology-warts-and-all-part-3/20843/Psychodermatology: A Review
https://practicaldermatology.com/topics/practice-management/psychodermatology-a-review/21180/Melasma Treatments: A Review of Laser Therapies and the Integration of Reflectance Confocal Microscopy
https://practicaldermatology.com/topics/general-topics/melasma-treatments-a-review-of-laser-therapies-and-the-integration-of-reflectance-confocal-microscopy/21363/Reflectance confocal microscopy may play a role in melasma stratification and treatment assessment.Basal Cell Carcinoma in Skin of Color: Diagnosis and Treatment Considerations
https://practicaldermatology.com/topics/general-topics/basal-cell-carcinoma-in-skin-of-color-diagnosis-and-treatment-considerations/21177/BCC may be less common in more darkly pigmented skin, but it occurs, and diagnosis may be delayed. Appropriate treatment is crucial.Anti-Semitism and Dermatologists
https://practicaldermatology.com/series/editors-message/anti-semitism-and-dermatologists/23988/(A Personal Narrative from the Editor)Medical Education and Technology: Intertwined like the Rod of Asclepius
https://practicaldermatology.com/columns/clinical-focus-1/medical-education-and-technology-intertwined-like-the-rod-of-asclepius/23453/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20495/Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.